Searched for
IQVIA
UK approves Novo weight-loss pill to edge open European marketBritain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...- Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...
- Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
- Alembic gets USFDA nod for generic levothyroxine sodium tabletsAlembic Pharmaceuticals has secured final approval from the US health regulator for its generic levothyroxine sodium tablets. This medicati...
- Alembic Pharma gets USFDA tentative nod for generic prostate cancer drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its generic version of Darolutamide tablets, targeting prostate c...
- Cipla gets USFDA nod for generic respiratory issues treatment inhalation aerosolPharma major Cipla has secured final approval from the US health regulator for its generic albuterol sulfate inhalation aerosol. This marks...
- Eli Lilly Foundayo weight-loss pill vs Novo Nordisk Wegovy oral obesity treatment tablets: Which medicine is the most prescribed across U.S.?Eli Lilly Foundayo was approved in the U.S. on April 1, with prescriptions accepted immediately on LillyDirect, while shipping started on A...
- Pharmaceutical logistics in demand as war rattles supply chainsMedicines are vital but useless if lost or spoiled. Pharmaceutical logistics ensures their safe delivery. DHL's Florstadt campus near Frank...
- Sun Pharma most exposed Indian company to Trump's new tariff threat, warns JefferiesIndian drug maker Sun Pharma faces significant exposure to potential US tariffs on medicines. Global brokerage Jefferies warns that while g...
- China pulls ahead in biologics race, forcing Indian drugmakers to rethink strategyIndia's drug companies face a tough race in the global biologics market. China is quickly becoming a leader in biotech supply chains. India...
- Anti-diabetic drugs lead growth in pharmaceuticals marketThe pharmaceuticals market in India is witnessing significant growth, with anti-diabetic drugs leading the way with over ₹155 crore in valu...
- Zydus Lifesciences gets USFDA nod for asthma treatment drugZydus Lifesciences Ltd receives final USFDA approval to market generic Theophylline extended-release tablets of strengths 300 mg and 450 mg...
- Zydus Lifesciences gets USFDA approval for generic acne treatment gelZydus Lifesciences Ltd received final approval from the US Food and Drug Administration (USFDA) to market its generic version of Dapsone ge...
- Pharma growth shrinks to 4.5% in June as Covid-led segments show decrease in salesIndia's pharmaceutical market contracted by 4.5% in June due to a fall in anti-infectives and respiratory drug sales as Covid cases decreas...
- JB Pharma acquires rosuvastatin brand from Glenmark for Rs 314 croreThe acquisition will be funded through long term debt and internal accruals. Razel ranks among the top 10 brands in India in the rosuvastat...
- Zydus Lifesciences gets USFDA nod for 2 generic drugsThe tentative approval granted by the US Food and Drug Administration (USFDA) to the company's arm Zydus Worldwide DMCC to market Valbenazi...
- Zydus gets USFDA nod to market generic antifungal medicationEfinaconazole is an antifungal used for the topical treatment of Onychomycosis of the toenails due to Trichophyton rubrum and Trichophyton ...
- Sun Pharma gets USFDA nod for generic drug Mesalamine extended release capsulesThe company has received approval from the US Food and Drug Administration (USFDA) for the product, a generic version of Pentasa extended r...
- Alembic Pharma gets USFDA nod for anti-viral drugQuoting IQVIA data, Alembic Pharma said Amantadine Hydrochloride Tablets, 100 mg have an estimated market size of USD 13 million for twelve...
- Lupin launches contraceptive drug in the US marketThe company has launched the product in the US after having received approval from the USFDA earlier, Lupin said in a BSE filing.
Load More
